-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Currently, the global COVID-19 vaccination plan prioritizes cancer patients, including the use of mRNA vaccines
CRS/cytokine storm is a systemic inflammatory response characterized by excessive release of cytokines (ie, INF-γ, IL-6, IL-10, and IL-2R are elevated)
A 58-year-old man started anti-PD -1 monotherapy (an experimental ICI in an ongoing interventional clinical trial; NCT02715284) for colorectal cancer (MMRd CRC) with mismatch repair defects that have metastasized to the mesentery and rectus ) Treatment
Given that cancer patients are excluded from the SARS-CoV-2 vaccine research and are currently in a priority position in the global COVID-19 vaccination program, this case prompts people to look forward to the safety of the COVID-19 vaccine in cancer patients Pharmacovigilance
references
referencesLewis Au et al.
Lewis Au et al.